Monitoring leg swelling in heart failure to reduce hospital stays
Part of Heart & circulation clinical trials.
This trial tests a new home monitoring device for people with heart failure and leg swelling. The device helps track fluid changes early, so you may be able to avoid hospital stays.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been diagnosed with heart failure.
- You have moderate to severe swelling in your legs.
- You live in the UK and your home can fit a small monitoring device.
- You either take a high dose of water pills (diuretics) daily, take them only when needed, or have an implanted heart monitor.
- You do not have both feet amputated, are not bed-bound most of the day, and do not need a wheelchair inside your home.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people with chronic heart failure who have swelling in their feet and legs and struggle to follow their care plan. It aims to reduce hospital visits by improving daily monitoring and medication use.
This trial tests a device to help the kidneys remove excess fluid in people hospitalized for worsening heart failure who are not responding well to standard diuretic (water pill) therapy. It aims to improve heart and kidney function.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests a new way to manage fluid levels in people hospitalized for heart failure. It aims to help doctors adjust treatment to keep you from coming back to the hospital.
This trial tests whether a wearable home monitoring system (myCordella™) can help people with moderate heart failure (NYHA class II or III) by tracking heart pressure and supporting follow-up care. It may help detect changes earlier so clinicians can adjust treatment sooner.
This trial tests a new way of caring for heart failure that combines in-person clinic visits with at-home monitoring using digital tools. If you join, you may be able to have more of your check-ups from home, which could be more convenient and help your care team catch problems early.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.